The Future of Pharma: Embracing Continuous Manufacturing

Continuous manufacturing (CM) is a modern manufacturing trend. Industries ranging from paper to petrochemicals

Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy

One of the most promising developments in the constantly developing field of medicine is pharmacologists.

The Impact of Adjuvant Technology on Vaccine Development

Adjuvant technology can improve vaccination effectiveness by activating the immune system, resulting in a stronger immune response.

Willow Announces Partnership with a Leading Pharma Firm To Develop Sustainable Intermediates

The Nasdaq-listed biopharma company and Willow Biosciences Inc. will work together to create new sustainable manufacturing routes for essential intermediates and active pharmaceutical ingredients (APIs). Willow Biosciences Inc. is a leading...

Exploring the Advantages of Pharmaceutical Pellets in Drug Delivery Systems

Pharmaceutical pellets are designed to release the medication slowly over a period of time, allowing for a more controlled and sustained release of the drug into the body. This method of delivery is particularly beneficial for medications that req...

Challenges Faced in Manufacturing Active Pharmaceutical Ingredients

Manufacturing of Active Pharmaceutical Ingredients (APIs) is a critical step in the productionof pharmaceutical drugs.

Why Ayurvedic and Herbal Brands Should Consider Contract Manufacturing

Contract manufacturing can assist Ayurvedic and Herbal Brands expand their product lines rapidly and in an efficient manner.

Novartis To Acquire US Firm Chinook Therapeutics For $3.5 Billion

In a $3.5 billion transaction, Novartis will acquire US-based Chinook Therapeutics, a clinical-stage biopharmaceutical business. Upon reaching specific regulatory milestones, Chinook common investors will earn $3.2 billion and $0.3 billion in cash...

Novo Nordisk Ventures DKK 15.9 Billion in Expansion of Manufacturing Facilities in Denmark

A current Active Pharmaceutical Ingredient (API) production plant in Denmark will be expanded as part of Novo Nordisk's announced plans to invest 15.9 billion Danish kroner beginning in 2023 for the company's future portfolio of major chronic...

Innovative Business Models Shaping India's Diagnostics Industry

The diagnostics industry is increasingly being shaped by innovative business models such as franchising, subscription-based services, and digital platforms.